Skip to content
FrontierPicks

Watching

HAWK · HawkEye 360

Conviction · Medium · more likely to lead the S&P 500 over the next three months, by a modest margin

Wrong if: a daily close below $14.60

Event-driven Catalyst · Defense & aerospace

Note written ·

Price against the kill line

26.4% clear of its kill line on the 17 November 2026 close.

How to read this

The red mark is the price level of the published kill line: a close through it (a weekly close, on a weekly line) would prove the research note wrong on price. The dot is where the stock closed on 17 November 2026; a dot left of the mark has closed through its line.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

HAWKHawkEye 360
$14.60
$18.45
26.4%well clear

Three months against the kill line

HAWK daily closes from 19 August 2026 to 17 November 2026, last $18.45, against its kill line: a daily close below $14.60. 19 August 2026: $21.9120 August 2026: $21.6121 August 2026: $21.4524 August 2026: $20.3425 August 2026: $21.4926 August 2026: $21.3527 August 2026: $20.4728 August 2026: $19.3831 August 2026: $18.961 September 2026: $18.362 September 2026: $17.653 September 2026: $17.324 September 2026: $17.368 September 2026: $17.839 September 2026: $16.4510 September 2026: $16.4211 September 2026: $16.3014 September 2026: $16.3815 September 2026: $16.4916 September 2026: $16.1717 September 2026: $17.2818 September 2026: $16.2721 September 2026: $16.2622 September 2026: $15.9723 September 2026: $15.8324 September 2026: $16.0025 September 2026: $16.1028 September 2026: $15.5129 September 2026: $15.3830 September 2026: $15.101 October 2026: $14.732 October 2026: $14.815 October 2026: $14.386 October 2026: $14.377 October 2026: $14.088 October 2026: $14.009 October 2026: $13.7012 October 2026: $13.4513 October 2026: $12.9814 October 2026: $12.3815 October 2026: $12.8916 October 2026: $12.4419 October 2026: $12.1020 October 2026: $11.9021 October 2026: $11.8522 October 2026: $11.6723 October 2026: $12.2826 October 2026: $12.7627 October 2026: $13.5228 October 2026: $13.2729 October 2026: $14.2130 October 2026: $13.552 November 2026: $13.653 November 2026: $14.594 November 2026: $13.375 November 2026: $12.766 November 2026: $14.799 November 2026: $15.0610 November 2026: $14.9711 November 2026: $15.2612 November 2026: $14.6713 November 2026: $18.1616 November 2026: $18.5117 November 2026: $18.45

Daily closes, to . Red: the kill line, a daily close below $14.60, set on 15 November 2026. The shares are down 15.8% since the close; the S&P 500 is down 4.5% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close below $14.60, under the 50-day moving average, which would show the market rejecting the raised 2026 outlook; or full-year 2026 revenue below the $225 million low end of guidance.

Research onlyNot in the portfolio.

Catalyst

The portfolio's record →

The business · as of

HawkEye 360 operates more than 30 satellites that detect and locate radio-frequency signals. It sells the data and analysis to the US government and allied nations through tasking contracts, subscriptions and dedicated satellite capacity. Revenue was $59.3 million in the quarter to 30 September 2026.

What is changing, and what follows · as of

What is changing now
On 12 November 2026 the company raised 2026 revenue guidance to $225–227 million from $215–220 million and said it had signed about $135 million of contracts since 1 October (8-K earnings release).
What follows for the company
Backlog rose to $300.3 million at 30 September 2026 and cash stood at $494.9 million with no long-term debt, but gross margin fell to 71.2% from 83.1% a year earlier.
What follows for its customers, suppliers and competitors
Customers are mainly the US Department of War and intelligence agencies, plus allied governments in Europe and Japan; more than $70 million of the new awards are European follow-ons, and none of the buyers is a listed company.

What the price assumes · as of

At the 13 November 2026 close (filed inputs to 13 November 2026) the market value is $1,804 million and the shares trade at 2.2 times book value; enterprise value, EV/sales, P/E and free-cash-flow yield are not available. That price holds only if revenue keeps growing near the 84% of the latest filed quarter while the operating margin, −7.4% in that quarter, turns positive.

Key figures from the filings · Technology

Quarter to 30 September 2026, filed 13 November 2026

Revenue, latest quarter ($M)
59.3
Revenue, change on a year (%)
+84.3
Gross margin (%)
71.2
Operating margin (%)
−7.4
All filed numbers

What HawkEye 360 reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them
Quarter to Revenue ($M) On a year (%) Gross margin (%) Operating margin (%)
first filed 59.3 +84.3 71.2 −7.4
first filed 49.8 +87.1 70.2 −23.2
first filed 49.8 +116.5 67.7 −11.3
first filed 32.2 — 83.1 5.4
first filed 26.6 — 81.3 3.0
Income Quarter to 30 September 2026, filed 13 November 2026
Pre-tax income ($M) 0.0
Net income ($M) −0.2
Diluted shares, change on a year (%) against the quarter to 30 September 2025 +584.1
Cash flow
Operating cash flow ($M) Not available
Capital spending ($M) Not available
Free cash flow ($M) Not available
Balance sheet At 30 September 2026, filed 13 November 2026
Cash and short-term investments ($M) 495
Debt ($M) Not available
Net cash, cash less debt ($M) Not available
Deferred revenue ($M) 29.9
Backlog, orders not yet delivered ($M) 133
Receivables ($M) 41.4
Inventory ($M) 3.5
Shareholders' equity ($M) 805
Valuation At the 17 November 2026 close, filed figures to 13 November 2026
Market value ($M) 1,832
Enterprise value, market value plus net debt ($M) Not available
Enterprise value to sales (×) Not available
Enterprise value to operating income (×) Not available
Price to earnings (×) Not available
Price to book value (×) 2.3
Free-cash-flow yield (%) Not available

Short interest (FINRA, settled 30 October 2026, published 10 November 2026): 3.0% of shares outstanding sold short, 1.9 days of average trading to cover, −20.3% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date
Window Bought Sold
90 days Not available yet Not available yet
12 months Not available yet Not available yet

The thesis

HawkEye 360 is modestly more likely than not to beat the S&P 500 over the next three months. On 12 November 2026 it raised its 2026 revenue outlook to $225–227 million and reported $135 million of new contracts signed since 1 October, and the shares still trade far below their $26 offering price of 6 May 2026. The fourth-quarter report, expected around March 2027, shows whether the international growth carries into 2027.

The rating is Medium because the case rests on filed numbers. Third-quarter revenue was $59.3 million, up 84% from $32.2 million a year earlier, according to the company's 12 November 2026 earnings release. The release also reported $494.9 million of cash and no long-term debt at 30 September 2026. Against that, the shares fell 21.6% over the three months to 13 November 2026. Gross margin has dropped from a year earlier, and executives sold stock under Rule 10b5-1 plans in September and October.

Bullish and bearish views on HawkEye 360, Inc.

The bull case on HawkEye 360, Inc. (HAWK), in brief: revenue outlook raised after the quarter. The bear case: margins are moving the wrong way.

Bull case

  • Revenue outlook raised after the quarter. On 12 November 2026 the company lifted 2026 revenue guidance to $225–227 million from $215–220 million and set adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, a non-GAAP measure) at $38–40 million, according to the 8-K earnings release and Benzinga. Third-quarter revenue of $59.336 million beat the $56.348 million consensus estimate Benzinga cited.
  • Orders keep arriving after the quarter. The company signed about $135 million of contracts after 30 September 2026, more than $70 million of them follow-on European awards, and backlog reached $300.3 million at 30 September 2026, up from $292.2 million at 30 June 2026 (12 November 2026 release).
  • International demand is the growth engine. International revenue was $23.3 million in the third quarter, up 76% from a year earlier and 11% from the second quarter's $21.0 million. Chief Executive John Serafini said on 12 November 2026 that he expects international expansion to continue.
  • Cash covers the build-out. Cash was $494.9 million at 30 September 2026 after the company repaid $49.5 million of term loans in the first nine months (12 November 2026 release). Third-quarter free cash flow was $0.1 million, so the satellite spending is now roughly self-funded.
  • More capacity in orbit. Clusters 15 and 16 launched in October 2026, six satellites in all, and the company says it has launch slots secured through 2028 (20 October 2026 and 23 October 2026 company releases).

Bear case

  • Margins are moving the wrong way. Gross margin was 71.2% in the quarter to 30 September 2026, down from 83.1% a year earlier, and the operating margin was −7.4% against 5.4% (10-Q filed 13 November 2026). Net loss for the first nine months of 2026 was $24.4 million, against net income of $1.7 million a year earlier.
  • Insiders have been selling. SEC Form 4 filings show the chief executive sold 92,329 shares at $14.78 on 1 October 2026 after exercising options at $0.23, and director Arthur Money sold 50,000 shares at $16.41 on 11 September 2026. Both executive sales and the chief legal officer's were under Rule 10b5-1 plans.
  • Share count jumped with the listing. Shares outstanding rose to 99,091,643 at 30 September 2026 from 4,168,374 at 31 December 2025 as preferred stock converted at the May listing (12 November 2026 release), and diluted shares were up 584.1% from a year earlier (10-Q).
  • A few government buyers dominate. In 2025, US customers, mostly government agencies, made up 61% of revenue and Japan 16%, and the prospectus of 6 May 2026 says a substantial portion of revenue comes from a limited number of customers.

Price setup

The shares closed at $18.16 on 13 November 2026, above the 50-day moving average of $14.63 on the same date. Over three months they lost 21.6%, so the gain after the report has recovered only part of the fall from late summer. The $26 initial public offering price of 6 May 2026 remains well above the market.

Insider sales mark where holders took money off the table: $16.24–16.41 in mid-September and $14.78 on 1 October 2026, per Form 4 filings. Piper Sandler raised its target to $24 on 13 November 2026 and kept an Overweight rating (Benzinga). The case turns on the shares holding above the 50-day average while the market prices in the raised outlook. Across US stocks, no reliable effect has been found so far for what follows a large one-day jump.

Catalysts ahead

  • ~12 March 2027 (est.): Fourth-quarter and full-year 2026 results, with 2027 guidance. Shows whether 2026 revenue lands inside the $225–227 million range, whether gross margin recovers from 71.2%, and whether 2027 guidance carries the international growth forward.

What would change the view

A daily close below $14.60, under the 50-day moving average, which would show the market rejecting the raised 2026 outlook; or full-year 2026 revenue below the $225 million low end of guidance.

The risks this note tracks, each with what would confirm it:

  • Gross margin keeps sliding as dedicated-capacity and sovereign-system work grows, which delays operating profit. Confirmed by: fourth-quarter 2026 gross margin below the third quarter's 71.2% in the report expected around March 2027.
  • US defense or intelligence budget delays push back tasking orders from the company's largest customers. Confirmed by: backlog falling below the $300.3 million reported at 30 September 2026, or management citing delayed US government awards.
  • International demand slows after the European follow-on awards. Confirmed by: international quarterly revenue falling below the third quarter's $23.3 million.
  • Former pre-IPO holders keep selling stock now that the listing restrictions have passed. Confirmed by: further Form 4 open-market sales by executives or directors, or a secondary offering filed with the SEC.

What it trades with

HawkEye 360 sells signals intelligence, located radio-frequency data, to defense and intelligence agencies, so its shares are tied to US defense and intelligence budgets and, increasingly, to European defense spending. More than $70 million of its post-quarter awards were European follow-ons. A common market view is that recently listed space and defense names trade together on sentiment. That would link HawkEye 360 to its theme peers Firefly Aerospace (FLY) and StandardAero (SARO) more than its own contract flow does. Dispersion is high across the market. The standard deviation of 63-session returns across liquid US stocks was 27% in 2026, so one small-cap's three-month result carries a wide range of outcomes.

Caveats

  • HawkEye 360 is a Delaware public benefit corporation, so its directors must weigh a stated public benefit alongside shareholder returns. IPO prospectus (Form 424B4), 6 May 2026 · as of
  • HawkEye 360 is an emerging growth company and uses reduced public-reporting requirements. IPO prospectus (Form 424B4), 6 May 2026 · as of
  • The shares listed on the New York Stock Exchange at an offering price of $26.00, with 16,000,000 shares sold by the company. IPO prospectus (Form 424B4), 6 May 2026 · as of
The evidence, claim by claim (8)
  1. Third-quarter 2026 revenue was $59.3 million, up 84% from $32.2 million a year earlier; net loss was $0.2 million. Third-quarter 2026 earnings release (8-K exhibit 99.1) · as of
  2. Full-year 2026 revenue guidance was raised to $225–227 million from $215–220 million; adjusted EBITDA guidance is $38–40 million. Third-quarter 2026 earnings release; Benzinga · as of
  3. Backlog was $300.3 million at 30 September 2026, up from $292.2 million at 30 June 2026. Third-quarter 2026 earnings release (8-K exhibit 99.1) · as of
  4. The company signed about $135 million of contracts after 30 September 2026, more than $70 million of them follow-on European awards. Third-quarter 2026 earnings release (8-K exhibit 99.1) · as of
  5. Cash was $494.9 million and long-term debt zero at 30 September 2026, after $49.5 million of term loans were repaid in the first nine months. Third-quarter 2026 earnings release (8-K exhibit 99.1) · as of
  6. Gross margin was 71.2% in the third quarter of 2026, down from 83.1% a year earlier; operating margin was −7.4% against 5.4%. Form 10-Q for the third quarter of 2026 · as of
  7. Chief Executive John Serafini sold 92,329 shares at $14.78 on 1 October 2026 under a Rule 10b5-1 plan after exercising options at $0.23. SEC Form 4 filed 2 October 2026 · as of
  8. Piper Sandler kept an Overweight rating and raised its price target to $24. Benzinga, 13 November 2026 · as of

Sources

Related · shared themes

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X